120 likes | 312 Views
2. Background. Previous studies have examined the costs and benefits of a single treatment episode Drug abuse is a chronic relapsing condition and is typically not successively treated in one treatment episodeSimulation models are useful tools to represent progression of chronic conditions even th
E N D
1. Costs and Benefits of Methadone Treatment: Results from a Lifetime Simulation Model
2. 2 Background Previous studies have examined the costs and benefits of a single treatment episode
Drug abuse is a chronic relapsing condition and is typically not successively treated in one treatment episode
Simulation models are useful tools to represent progression of chronic conditions even though typically only observe individuals over short time periods
Simulation models have been used to evaluate costs and benefits of treatment for chronic conditions, such as coronary heart disease, diabetes, depression
Zaric et al. (2000) developed a dynamic compartmental model to evaluate the cost-effectiveness of expanding methadone treatment
3. 3 Model Description (I) Monte Carlo simulation of 1 million men and women from general population ages 18 to 60
Monthly transitions are governed by random draws from probability distributions
Outcomes:
Heroin use
Methadone treatment
Criminal behavior/criminal justice
Time spent incarcerated
Employment
Health care
4. 4 Model Description (II)
5. 5 Model Description (III) Estimated QALYS, lifetime crime and criminal justice (CJ) costs, earnings, health care (HC) costs
Lifetime Economic Benefits = discounted present value of (Earnings HC Costs CJ Costs)
Lifetime Costs = discounted present value of treatment costs
All future values are discounted at r = 0.03 per year
6. 6 Data The model requires a large number of parameter values
To the extent possible, we identified parameters from the literature or readily accessible databases
Annual transition data were converted into corresponding monthly value
When data were not available, parameters were hypothesized to match models moments to observed data
7. 7 Selected Results (I) Percent Ever-Users Who Went to Treatment 59%
Number of Times Treatment Participants Went to Treatment 3.4
Cumulative Years in Treatment 2.4
Percent of Ever-Users Who Committed a Crime 75%
Percent of Ever-Users Who Were Incarcerated 51%
Mean Lifetime Crime and Criminal Justice Costs
Never-Users $70,017
Ever-Users $1,061,639
Mean Lifetime Earnings
Never-Users $467,463
Ever-Users $236,012
Mean Lifetime Health Care Costs
Never-Users $18,531
Ever-Users $17,431
8. 8 Selected Results (II)
9. 9 Selected Results (III)
10. 10 Selected Results (IV)
11. 11 Discussion (I) Simulation models are a useful tool for modeling chronic conditions such as drug use
To compare to the literature, we estimated the benefits and costs of a single treatment episode; we found a benefit-cost ratio of 4.9 for treatment, comparable to findings in the literature
In contrast, comparing the baseline model to a world without treatment yields a benefit-cost ratio of 37.7 for having lifetime treatment available
Magnitude of lifetime benefit-cost ratio illustrates that treatment has multiplicative effect that yields greater than proportional increases in lifetime benefits
12. 12 Discussion (II) Limitations
Model makes many simplifying assumptions
Values for several parameters were assumed
Sensitivity analysis showed that for the most part, model was not sensitive to assumed parameters. An exception was the model showed some sensitivity to criminal behavior parameters
Focuses only on outpatient methadone treatment
Hope that lifetime simulation model that captures dynamics of use and treatment can help policy makers make better judgments about current resource allocation